Alere (ALR) Stock Price, News & Analysis

Company Overview

Alere Inc. is a provider of health information through diagnostic tests. The Company's segments include professional diagnostics, consumer diagnostics, and corporate and other. The professional diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests marketed to medical professionals and laboratories for detection of diseases and conditions within its areas of focus. The consumer diagnostics segment consists primarily of manufacturing operations related to its role as the exclusive manufacturer of products for SPD Swiss Precision Diagnostics (SPD), its joint venture with The Procter & Gamble Company (P&G). The Company's professional diagnostic solutions allow patients and their healthcare providers to work together to manage patients' conditions over the continuum of care, from the hospital to home. The Company offers lines of drugs-of-abuse tests, reagent systems and laboratory testing options.

Key Stats

• Today's Range: $1.32 to $1.32
• 50-Day Range: N/A
• 52-Week Range: $34.41 to $51.00
• Volume: N/A
• Average Volume: 40,839 shs
• Market Capitalization: $43.05 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ALR Stock Analysis - Frequently Asked Questions

How were Alere's earnings last quarter?

Alere Inc. (NYSE:ALR) posted its earnings results on Friday, November, 4th. The medical research company reported $0.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.54 by $0.35. The firm's revenue for the quarter was down 3.6% compared to the same quarter last year.

What other stocks do shareholders of Alere own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Alere investors own include Morgan Stanley (MS), BioTelemetry (BEAT), Abbott Laboratories (ABT), Edwards Lifesciences (EW), FireEye (FEYE), Twitter (TWTR) and AEGR (AEGR).

Company Calendar

• Last Earnings: 11/04/2016
• Today: 4/27/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Skilled nursing care facilities
• Sub-Industry: Health Care Supplies
• Current Symbol: NYSE:ALR
• CIK: 1145460
• Web: www.alere.com
• Phone: +1-781-6473900
• Fax: 617-796-8385
• Employees: 10,400
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($1.20)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-29,920,000.00
• Net Margins: -5.34%
• Pretax Margin: -5.29%
• Return on Equity: -20.78%
• Return on Assets: -9.02%

Debt

• Debt-to-Equity Ratio: 0.45
• Current Ratio: 1.58
• Quick Ratio: 1.58

Sales & Book Value

• Annual Sales: $934.59 million
• Price / Sales: 0.05
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $5.72 per share
• Price / Book: 0.23

Miscellaneous

• Outstanding Shares: 32,610,000
• Free Float: 29,870,000
• Market Cap: $43.05 million
• Optionable: Optionable
• Beta: 0.85